1
1
Rapid Transepithelial Transport of Prions Following Inhalation 2
3
Running Title: In Vivo Transport of Prions Across Nasal Mucosa 4
5
Anthony E. Kincaid1,2,3# Kathryn F. Hudson1*, Matthew W. Richey1 and Jason C. Bartz3 6
7
Department of Physical Therapy,1 Department of Biomedical Sciences,2 and 8
Department of Medical Microbiology and Immunology,3 Creighton University, Omaha, 9
Nebraska 68178 10
*Current address: Department of Pharmacology, Emory University, Atlanta, Georgia 11
30322-4218 12
13
14
Abstract word count: 245 15
Text word count: 4,490 16
17
Corresponding author E-mail: [email protected] 18
Copyright © 2012, American Society for Microbiology. All Rights Reserved.J. Virol. doi:10.1128/JVI.01930-12 JVI Accepts, published online ahead of print on 12 September 2012
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
2
Abstract 19
Prion infection and pathogenesis is dependent upon the agent crossing an epithelial 20
barrier to gain access to the recipient nervous system. Several routes of infection have 21
been identified, but the mechanism(s) and timing of in vivo prion transport across an 22
epithelium have not been determined. The hamster model of nasal cavity infection was 23
used to determine the temporal and spatial parameters of prion-infected brain 24
homogenate uptake following inhalation and to test the hypothesis that prions cross the 25
nasal mucosa via M cells. A small drop of infected or uninfected brain homogenate was 26
placed below each nostril where it was immediately inhaled into the nasal cavity. 27
Regularly-spaced tissue sections through the entire extent of the nasal cavity were 28
processed immunohistochemically to identify brain homogenate and the disease-29
associated isoform of the prion protein (PrPd). Infected or uninfected brain homogenate 30
was identified adhering to M cells, passing between cells of the nasal mucosa and 31
within lymphatic vessels of the nasal cavity at all time points examined. PrPd was 32
identified within a limited number of M cells 15-180 minutes following inoculation, but 33
not in the adjacent nasal associated lymphoid tissue (NALT). While these results 34
support M cell transport of prions, larger amounts of infected brain homogenate were 35
transported paracellularly across the respiratory, olfactory and follicle associated 36
epithelia of the nasal cavity. These results indicate prions can immediately cross the 37
nasal mucosa via multiple routes and quickly enter lymphatics where they can spread 38
systemically via lymph draining the nasal cavity. 39
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
3
Introduction 40
The prion diseases are a group of fatal neurodegenerative diseases that affect animals, 41
including humans. There is considerable evidence to support the hypothesis that the 42
infectious agent is largely if not entirely PrPSc, a misfolded conformation of the normal 43
prion protein, which is designated as PrPC (8, 12, 18, 51, 78, 85). The generation of 44
infectious prions is thought to occur when PrPSc comes into direct contact with PrPC and 45
converts the native protein into a misfolded conformation. The misfolded isomer has 46
distinct biological and physical properties; including the ability to self-propagate, 47
aggregate and cause disease (9, 14, 17, 24, 66). 48
While human prion diseases are rare, the prevalence of some animal prion diseases is 49
relatively high and in some cases increasing. For example the prevalence of chronic 50
wasting disease (CWD), a prion disease of deer and elk, can be as high as 15% in 51
some free-ranging populations and 80-89% in captive herds [54, 55, 57, 87). The 52
distribution of CWD in cervid populations in North America has expanded since it was 53
first reported in Colorado and Wyoming in the 1980s and with the recent identification of 54
infected animals in Michigan, Texas and Iowa has now been detected in 18 states and 2 55
Canadian provinces [http://www.cdc.gov/ncidod/dvrd/cwd/]. One of the characteristic 56
features of prion diseases is that they can be horizontally transmitted between animals, 57
but neither the source nor the mode of transmission in free ranging populations of 58
animals is known (56, 77). There is increasing evidence for infectious prions existing in 59
a number of bodily fluids including: urine (31, 62, 74, 76), semen (70), saliva (31, 50 60
53), nasal secretions (7), blood (13, 37, 53), milk (43, 47, 48) and feces (45, 71, 84). In 61
addition there is evidence that prion infectivity resides in: placenta (2, 68), decaying 62
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
4
carcasses (56), antler velvet (4) and inanimate objects such as fence post and feeding 63
trough surfaces (49). Infectious prions are particularly stable and have been shown to 64
retain their infectivity after years in the environment, therefore the ongoing transmission 65
of disease in free-ranging animals is of great concern (10, 30, 40, 72,75). 66
The oral route of infection has been established in the spread of prion diseases caused 67
by the consumption of prion-contaminated food sources including the bovine spongiform 68
encephalopathy (BSE) outbreak in the United Kingdom (16), the spread of kuru in New 69
Guinea (26), and the rare occurrence of transmissible mink encephalopathy (TME) that 70
affected ranch-raised mink (52). While the oral route of infection may be involved in the 71
transmission of disease in free-ranging animals, other routes of prion entry may exist 72
(79). Recently the nasal cavity has been demonstrated experimentally to be an 73
effective route of prion infection in hamsters, mice and sheep following intra- or 74
extranasal inoculation of infected brain homogenate (6, 32, 42, 73). Furthermore, 75
aerosolization of prions using a nebulizer followed by exposure to the nose or snout of 76
mice also resulted in the development of disease in cervidized, wild-type and 77
immunodeficient mice (19, 34). Given that animal populations that are susceptible to 78
prion diseases use their highly developed olfactory systems for the detection of food 79
and predators, and for reproductive and exploratory purposes the mucosal surface of 80
the nasal cavity may be a site of initial contact of inhaled materials harboring prions. 81
Whether the initial site of mucosal contact is in the gut or the nasal cavity, the infectious 82
agent must be transported across a mucosal epithelium to gain entry into the body 83
where it can replicate and cause disease. There is disagreement about the location and 84
mechanism of the transepithelial transport of prions following ingestion with in-vitro 85
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
5
evidence for M cell transport [35], co-transport of prions with ferritin [58, 80], and 86
laminin-mediated binding and endocytosis of prions (60), all across Caco-2 human 87
epithelial cells. A second in vitro model of prion transport demonstrated that murine-88
adapted BSE crossed bovine M cells efficiently (59). In vivo experiments have 89
demonstrated evidence for both M cell-mediated, and non M cell-mediated 90
transepithelial transport of prion proteins following oral ingestion in mice and sheep 91
respectively (3, 20, 25, 36, 38, 46, 64, 83). The temporal parameters and the cell types 92
mediating the transepithelial transport of prions within the nasal cavity have not been 93
established. 94
The experiments reported here were designed to determine the location, cell type and 95
time course of the transepithelial transport of prions within the nasal cavity following 96
inhalation by hamsters in an in-vivo model of prion infection. An important component 97
of these experiments was the ability to test the hypothesis that M cells located in the 98
follicle associated epithelium (FAE) that overlies the NALT are responsible for the 99
transport of prions across the epithelium. 100
MATERIALS AND METHODS 101
Animal care. Procedures involving animals were preapproved by the Creighton 102
University Institutional Animal Care and Use Committee and done in accordance with 103
the Guide for the Care and Use of Laboratory Animals (63). Male adult golden Syrian 104
hamsters from Harlan Sprague-Dawley (Indianapolis, IN) were group housed in 105
standard cages with ad libitum access to food and water. 106
107
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
6
Animal Inoculations. Extranasal (e.n.) inoculations were performed as described 108
previously (42). Hamsters receiving e.n. inoculations were briefly anesthetized with 109
isoflurane (Webster Veterinary, Kansas City, MO), placed in a supine position and 10-110
100µl of brain homogenate was placed just inferior to each nostril (20-200µl total 111
volume). The brain homogenate was immediately inhaled into their nasal cavity; the 112
animals began to move freely in their cages within 1-2 minutes of the start of the 113
procedure. 114
Brain homogenate and control solutions. Dulbecco’s phosphate buffered saline 115
(PBS), India ink (colloidal carbon in water), or a 10% (wt/vol) brain homogenate from 116
either an HY TME-infected hamster (containing a 109.3 intracerebral 50% lethal dose 117
[LD50]/g) or uninfected hamster was used. India ink was used to identify M cells in the 118
FAE of the hamster nasal cavity (69). 119
Tissue Collection. Animals exposed to PBS, India ink, infected- or mock-infected brain 120
homogenate were reanesthetized following a specified survival period and transcardially 121
perfused with 50 ml of 0.01 M Dulbecco’s PBS followed by 50-75 ml of McLean’s 122
paraformaldehyde-lysine-periodate (PLP) fixative. Skulls were removed and placed in 123
PLP at room temperature overnight, then decalcified for 2 weeks at room temperature 124
with a solution change at 1 week (Decalcifying Solution, Richard-Allan Scientific, 125
Kalamazoo, MI). Using the hard palate for orientation the nasal cavity was excised 126
between the posterior edge of the incisors and the anterior edge of the seventh palatal 127
ridge, a length of about 12 mm. This block of tissue contains the entire nasal cavity, 128
including the NALT, olfactory and respiratory epithelia, but not the rostral vestibule 129
which is lined by a stratified squamous epithelium (1). This block was then cut and 130
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
7
divided into three 4 mm coronal slices, or sagittaly into single right and left halves, and 131
placed into a cassette for paraffin processing and embedding. Serial sections (7 µm) 132
were cut with a rotary microtome and mounted onto glass slides. A small number of 133
animals (2 untreated and 2 PBS inoculated animals) were immersion fixed in PLP for 1 134
week prior to decalcification and paraffin processing, not transcardially perfused, to 135
differentiate lymphatic vessels from blood vessels. 136
Histology. To establish the location and boundaries of the various types of epithelia 137
found within the nasal cavity, including the location of M cells, tissue sections from 138
untreated animals, or animals extranasally exposed to India ink or PBS were cleared, 139
dehydrated and stained with periodic acid-Schiff (PAS) or hematoxylin and eosin (H&E). 140
Pairs of tissue sections not further than 112 µm apart through the rostral-caudal extent 141
of the hamster nasal cavity were examined using an Olympus BX 40 light microscope to 142
demonstrate normal nasal mucosa morphology and the location of M cells. 143
Immunohistochemistry. Immunohistochemistry was performed to detect PrPd as 144
reported previously, and infected and mock-infected tissues were processed at the 145
same time using the same reagents (42). In brief, tissue sections were deparaffinized 146
and subjected to antigen retrieval in formic acid (95%) for 10 min at room temperature. 147
All of the following steps were carried out at room temperature; incubations were 148
separated by 3 rinses with 0.05% v/v Tween in Tris-buffered saline (TTBS). 149
Endogenous peroxidase and non-specific antibody binding were inhibited by incubating 150
the tissue sections in 0.3% H2O2/methanol for 20 min followed by incubation in 10% 151
normal horse serum in TTBS for 30 min. Visualization of the prion protein was carried 152
out using the avidin-biotin method. Incubation in anti-prion protein monoclonal antibody 153
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
8
(Clone 3F4; 1:600, Chemicon, Temecula, CA) was carried out for 2 hrs at room 154
temperature followed by incubation in biotinylated horse anti-mouse antibody (1:600, 155
Vector Laboratories, Burlingame, CA) for 30 min. The sections were placed in ABC 156
solution (1:200, Vector Laboratories, Burlingame, CA) for 15-20 min and subsequently 157
reacted in a solution containing filtered 0.05% diaminobenzidine tetrachloride (Sigma, 158
St. Louis, MO) with 0.0015% H2O2. The sections were counterstained with hematoxylin, 159
dehydrated through graded alcohols and coverslipped with Cytoseal-XYL (Richard Allan 160
Scientific, Kalamazoo, MI). GFAP IHC was carried out in a similar manner with the 161
following differences: there was no antigen retrieval step, the blocking step was carried 162
out using normal goat serum, the primary antibody was a rabbit anti GFAP polyclonal 163
(1:800, DAKO, Carpinteria, CA), and the secondary antibody was biotinylated goat anti-164
rabbit (1:800, Vector Laboratories, Burlingame, CA). Some sections were processed 165
identically with either the primary or secondary antibodies omitted, or with a mouse 166
immunoglobulin G isotype control (Abcam, Cambridge, MA) in place of the primary 167
antibody at the same concentration. Pairs of tissue sections not further apart than 56 168
µm were examined using an Olympus BX 40 light microscope. When additional 169
morphological detail was required adjacent tissue sections were processed for GFAP 170
IHC or stained with H&E. 171
RESULTS 172
Hamsters are obligate nose breathers, so a small amount of brain homogenate placed 173
just inferior to their nostrils was immediately inhaled into their nasal cavity. This 174
behavior precluded the need for placing a pipette inside the nose where it could injure 175
the nasal mucosa and expose brain homogenate directly to blood vessels and nerves. 176
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
9
Mucosal damage could lead to direct hematogenous spread and/or neuroinvasion, 177
which would complicate the interpretation of the transepithelial transport route and 178
mechanism(s). 179
Following inhalation of PBS (n=7), India ink (n=6), and infected (n= 35) or uninfected 180
(n= 15) brain homogenate hamsters were allowed to survive for 1-180 minutes prior to 181
initiating transcardial perfusion. Control animals were untreated (n=6). Regularly-182
spaced tissue sections were inspected for the presence of ink, GFAP or PrPd. The 183
average number of immunohistochemically-processed tissue sections analyzed per 184
animal was 366 (range: 150-640). Sagittaly sectioned nasal cavities produced fewer 185
tissue sections, as the nasal cavity is approximately twice as long as it is wide. GFAP is 186
the principle intermediate filament of astrocytes and therefore a component of both 187
infected and uninfected brain homogenate, while PrPd is found only in prion-infected 188
brain homogenate (8, 14, 21). Roughly 2/3rds of the tissue sections were processed 189
using GFAP IHC, since tissue morphology is better preserved using this procedure than 190
PrPd IHC, which requires the use of formic acid for antigen retrieval. The mucosal 191
surface and underlying lamina propria of tissue sections through the rostral-caudal 192
extent of each nasal cavity were inspected using a light microscope and brain 193
homogenate was identified with either GFAP or PrPd IHC. Brain homogenate was 194
identified in the nasal cavity of each experimental animal, but was not seen in untreated 195
animals or those who inhaled PBS. While there was more brain homogenate observed 196
within the nasal cavities of animals that inhaled larger volumes of brain homogenate, 197
the volume of brain homogenate was not related to the occurrence of transport. 198
Therefore the data for animals that inhaled different volumes of brain homogenate with 199
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
10
the same survival time was combined. Photomicrographs were taken wherever brain 200
homogenate was identified on the surface of, within, or deep to the nasal mucosa. 201
Omission of either the primary or secondary antibody or replacement of the primary 202
antibody with an isotype control resulted in a complete lack of staining (data not shown). 203
Hamster nasal cavity and light microscopic identification of M cells. The hamster 204
nasal cavity is lined by a variety of morphologically-distinct epithelia, including 205
respiratory, olfactory and FAE that lies adjacent to the NALT (Fig. 1A, 1B). M cells are 206
non-ciliated with a flattened apical surface and distinct intraepithelial pockets that 207
contain lymphoid cells (27, 44) and were identified in the FAE overlying the NALT in 208
H&E and PAS-stained tissue sections from untreated animals (Fig. 1C). M cells could 209
also be identified based on their ability to endocytose inhaled India ink (69). Ink particles 210
were identified within M cells in all 6 animals allowed to survive for from 5 to 30 minutes 211
after inhalation of 20-100µl of ink (Fig. 1D). Inspection of untreated or PBS-exposed 212
animals did not reveal any visible particulate matter on, or within, the M cells of the FAE 213
of the nasal cavity (Fig. 1C). The average number of tissue sections per animal that 214
were processed for H&E and PAS was 178 (range: 136-204). 215
Identification of inhaled prions. Prion-infected or uninfected brain homogenate was 216
identified within the nasal cavity of each animal following inhalation of brain homogenate 217
from either HY TME-infected, or mock-infected animals. Prion-infected or uninfected 218
brain homogenate was easily identified as aggregated or punctate brown particulate 219
matter within the nasal cavity airspace and lining the nasal mucosa using GFAP IHC 220
(Fig. 2). Prion-infected brain homogenate was identified using PrPd IHC as small brown 221
punctate particulate matter, while uninfected brain homogenate was unstained (Fig. 2). 222
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
11
PrPd IHC was used on tissue sections adjacent to GFAP-positive sections to confirm the 223
presence of PrPd in brain homogenate in animals that inhaled infected brain 224
homogenate. Brain homogenate from HY TME-infected animals was immunopositive 225
for GFAP and PrPd, while brain homogenate from uninfected animals was 226
immunopositive for GFAP but not for PrPd (Fig. 2). 227
M cell transport of brain homogenate. Based on previous reports of M cell 228
involvement in the transport of prions, M cells in the FAE adjacent to the NALT were 229
examined using a light microscope. Infected or mock-infected brain homogenate was 230
identified using GFAP IHC and was seen adhering to the FAE of 44 of 50 animals 231
following extranasal inoculation (Table 1; Fig. 3). The criterion used for positive 232
identification of brain homogenate or prions within M cells of the FAE was brown 233
punctate GFAP or PrPd immunoreactivity surrounded by M cell cytoplasm in the same 234
focal plane. Applying this criterion brain homogenate, either infected or uninfected, was 235
identified within M cells in 31 of the 43 hamsters that survived for 5 minutes or longer 236
(Table 1; Fig. 3). The number of M cells noted to contain brain homogenate for each 237
animal at each time point was counted to determine the period of maximal M cell 238
transport of brain homogenate. The greatest number of M cells containing brain 239
homogenate was in those animals that survived 10-60 minutes prior to initiating 240
perfusion, with a noticeable drop in the number of M cells containing brain homogenate 241
in those animals that survived 180 minutes (Table 1). Analysis of tissue deep to the M 242
cell layer was restricted to tissue sections processed for PrPd IHC since GFAP labels 243
thin diameter nonmyelinating Schwann cells (28, 39) which are located deep to M cells, 244
in the NALT, and coursing through the lamina propria (Fig. 2D and 4E). 245
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
12
Paracellular transport of brain homogenate occurs between olfactory, respiratory 246
and FAE cells within minutes of extranasal inoculation. Infected and uninfected 247
brain homogenate was detected penetrating or completely spanning the nasal mucosa 248
in 40 of the 50 animals extranasally inoculated in this experiment (Table 1; Fig. 4A and 249
4B). This was determined to be paracellular transport as brain homogenate was 250
located between intact epithelial cells, not within cells. This was confirmed by focusing 251
through the depth of the tissue section, and by examining the same cells on adjacent 252
tissue sections. Paracellular transport of brain homogenate was identified between 253
cells of the respiratory, olfactory and FAE of the nasal cavity (Fig. 4) and could be seen 254
extending into the underlying lamina propria in some cases (Fig. 4C and 4D). There 255
were multiple examples of transepithelial transport in all animals exhibiting transport; in 256
some cases multiple examples of paracellular transport were identified on single tissue 257
sections (Fig. 4B, 4D, and 4E). While paracellular transport was seen in animals from 258
all survival time points the number of animals that demonstrated paracellular transport 259
decreased in those animals that survived 180 minutes following inoculation by about 260
50% (Table 1). There were no examples of brain homogenate crossing the keratinized 261
stratified squamous epithelium that lines the vestibule of the proximal nasal cavity (33). 262
Prions quickly enter lymphatic vessels in the lamina propria but not the NALT. 263
Infected or uninfected brain homogenate was identified within the lumen of vessels in 264
the lamina propria of 47 of the 50 inoculated animals in this study (Table 1). These 265
vessels were determined to be predominantly lymphatic vessels and not blood vessels. 266
This distinction was based on the analysis of vessels from immersion fixed animals. 267
Immersion fixation does not rinse the blood cells from blood vessels, so blood vessels 268
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
13
were easily distinguished by the presence of red blood cells within their lumen, and 269
lymphatic vessels by the lack of blood cells. The location of lymphatic vessels was 270
found to be relatively constant between animals, especially for medium and large 271
diameter lymphatic vessels. Infected or uninfected brain homogenate was identified 272
inside the lumen of lymphatic vessels in the lamina propria of the nasal cavity of animals 273
at all survival time points (Figure 5). PrPd was not identified in the intraepithelial 274
pockets of M cells, or adjacent to, or within the NALT in any animal in this study. 275
DISCUSSION 276
The in vivo transport of infected brain homogenate containing PrPd across the nasal 277
mucosa began within minutes of inhalation and transport could still be detected in some 278
animals as long as 180 minutes following inhalation. Paracellular transport was 279
detected in animals that were perfused within 1-2 minutes after inhalation, while M cell 280
transport was first detected in animals that were perfused beginning 5 minutes after 281
inhalation. Both types of transport were detected in all remaining survival groups, with a 282
noticeable decrease in the number of animals demonstrating transport in the animals 283
that survived 180 minutes after inhalation. The rapid and prolonged period of 284
transepithelial transport of PrPd in the nasal cavity following inhalation is consistent with 285
the results of a study performed in a sheep gut-loop model of prion infection where prion 286
proteins were detected in the lumen of villous and submucosal lymphatics 15 minutes to 287
210 minutes following direct inoculation of an isolated loop of distal ileum in sheep (38). 288
The time frame, the type of transport (transcellular or paracellular) and the 289
cells/epithelia involved in the in vivo transport of prions following inhalation have been 290
identified. Most notably the paracellular transport of relatively large amounts of brain 291
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
14
homogenate between epithelial cells in the nasal cavity identified here has not been 292
described previously. While the sequence of events leading to the paracellular 293
transport of prions has not been determined, the mechanism of transepithelial transport 294
may involve passage of brain homogenate through existing gaps in the mucosa created 295
by the natural shedding of epithelial cells that has been reported in the intestine of mice 296
and humans (11, 41, 86). Utilizing existing gaps in the epithelia would be consistent 297
with the observed speed and physical dimensions of the transport of brain homogenate 298
reported here, where the passage of brain homogenate between cells often appeared to 299
be about one epithelial cell in width and occurred within minutes of inhalation (Figure 4). 300
The persistence and transepithelial transport of brain homogenate in the nasal cavity for 301
up to 3 hours after inhalation reported here is surprising as nasal mucociliary activity 302
results in measured mucus flow rates ranging from 0.9 to 11 mm/minute in different 303
areas of the rat nasal cavity and to average 1.3 mm/minute in mouse nasal cavity (29, 304
61). At these rates inhaled brain homogenate would be expected to be cleared from the 305
hamster nasal cavity in less than 60 minutes. This prolonged period of transport is 306
similar to what has been reported in the sheep gut-loop model where prions were 307
detected in submucosal lymphatics for up to 3.5 hours following inoculation (38). 308
A goal of these experiments was to test the hypothesis that prion entry following 309
inhalation was mediated via M cells of the FAE in the nasal cavity. Infected or 310
uninfected brain homogenate was seen within a relatively modest number of M cells 311
(average 1-5 per animal) in 31 of 50 animals in this study (Table 1). Given that the 312
efficiency of this route of inoculation has been determined to be 10-100 times greater 313
than per os inoculation (42), the number of animals demonstrating M cell transport, and 314
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
15
the number of M cells per animal transporting brain homogenate in this study were 315
lower than might be expected. This is in marked contrast to the robust paracellular 316
transport of PrPd in brain homogenate that was noted between cells of the olfactory, 317
respiratory and follicle associated epithelia that line the nasal cavity that has been 318
reported here (Table 1; Figure 4). The results of this study are consistent with a 319
relatively minor role for M cell transport in the transepithelial transport of prions following 320
inhalation, with a greater contribution coming from the paracellular transport of prions. 321
The limited number of examples of M cell involvement in PrPd transport following 322
inhalation was not due to a lack of exposure to brain homogenate, as almost all of the 323
animals examined in this study had multiple examples of brain homogenate resting on 324
FAE (Table 1). There are certain limitations to the interpretations that can be made 325
about a dynamic cellular process that occurs across a surface and over a period of time 326
when one is examining sections taken at specific time points. First, the transport of 327
brain homogenate across the M cells could happen very quickly, so that the chance of 328
identifying brain homogenate within the cell at any one time point is reduced, and the 329
numbers reported here would be artificially low. However, this scenario would not be 330
expected based on a report that the uptake and transfer of 600-750 nm latex particles 331
across M cells occurred over 90 minutes after contact with the FAE in a rabbit intestinal 332
loop model (67). Second, the transport of brain homogenate through M cells could 333
involve the phagocytosis and movement of very small particulate matter, some of which 334
could be beyond the resolution of a light microscope (~0.2 µm) and therefore not 335
detectable (65). The reported diameter of transported microparticles within M cells in 336
other studies is 0.02 to10 µm (22); therefore we may have been unable to identify the 337
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
16
smaller range of particulate brain homogenate that was contained within the M cells. 338
Regardless of resolution issues, definite identification of transcellular transport of prions 339
within M cells will require ultrastructural analysis. While the relative contribution to the 340
pathogenesis and the development of disease from the two routes identified in this 341
report remains to be determined, the apparently lesser role of M cell involvement in 342
prion transepithelial transport reported here is consistent with the sheep gut-loop model 343
of prion infection and in sheep orally inoculated with prions (3, 38, 46), where the FAE 344
and M cells do not appear to be involved in the transport of prion proteins across the gut 345
wall. 346
The results of this study indicate that PrPd can gain access to lymphatic vessels quickly 347
and that transport across the nasal mucosa and into the vessels persists for up to 3 348
hours after inhalation. It is not likely that the persistence of brain homogenate in the 349
lymphatics is simply due to a slow rate of lymph flow in the nasal cavity given that flow 350
rates have been reported to average 3-9 µm/second in different species (5, 23, 82) and 351
that dye placed in the nose reaches cervical lymph nodes in anywhere from 14-51 352
minutes, depending on the species (88). The presence of brain homogenate within 353
lymphatics is consistent with their role of draining fluid and macromolecules from the 354
extracellular matrix of the lamina propria in the nasal cavity. Material located in the 355
lamina propria is propelled towards lymphatic capillaries by interstitial fluid pressure and 356
enters the capillaries, which are made permeable by lack of a basement membrane and 357
the presence of anchoring filaments (for review see 81). Thus it appears that the 358
lymphatics, and subsequently the circulatory system, can serve as a route for the 359
systemic dispersion of prions that have been inhaled into the nasal cavity. Consistent 360
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
17
with this pattern of transepithelial transport following inhalation was the notable lack of 361
brain homogenate or PrPd adjacent to, or within, the NALT in any of the animals 362
examined in this study. While it is possible that direct neuroinvasion of prions may 363
occur via somatic and autonomic nerves located in the lamina propria of the nasal 364
cavity, this has not been reported. 365
366
Acknowledgments: The authors would like to sincerely thank Dr. Jacob Ayers, Albert 367
Lorenzo, Melissa Clouse, Shawn Feilmann and Theresa Lonmeth for their excellent 368
technical assistance with this work. 369
This work was supported by the National Institutes for Neurological Disorders and 370
Stroke (RO1 NS061994 and RO1 NS061994-03S1), Health Future Foundation 371
Discretionary Award #200600-713131d and by Grant G20RR024001 from the National 372
Center for Research Resources. The content is solely the responsibility of the authors 373
and does not necessarily represent the official views of the National Center for 374
Research Resources or the National Institutes of Health. 375
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
18
Table 1 Brain homogenate distribution in nasal cavity following inhalation 376
377
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
19
a Survival time till initiation of perfusion. Time till death included additional 10-12 minutes 378 b Total volume of mock-infected or HY-TME infected brain homogenate applied inferior to nostrils 379
FAE, follicle associated epithelium; bh, brain homogenate 380
Survival timea
Inoculumb
Location of brain homogenate
On FAE
Inside M cells
(# M cells)
Crossing between
epithelial cells
Deep to epithelium
1-2 min
(n=7)
Uninfected bh
(50-100 µl)
Infected bh
(50-200 µl)
2/2 0/2 2/2 2/2
5/5 0/5 4/5 5/5
5 min
(n=16)
Uninfected bh
(20-100 µl)
Infected bh
(20-200 µl)
6/6 2/6 (5) 5/6 6/6
10/10 8/10 (15) 9/10 9/10
10-20 min
(n=13)
Uninfected bh
(100 µl)
Infected bh
(100 µl)
2/3 2/3 (7) 1/3 2/3
10/10 10/10 (44) 10/10 10/10
60 min
(n=7)
Uninfected bh
(100 µl)
Infected bh
(50-100 µl)
1/2 1/2 (2) 1/2 2/2
5/5 5/5 (29) 5/5 5/5
180 min
(n=7)
Uninfected bh
(100 µl)
Infected bh
(100 µl)
1/2 1/2 (3) 1/2 2/2
2/5 2/5 (4) 2/5 4/5
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
20
Figure Legends 381
Figure 1. Hamster nasal cavity epithelial types and the identification of M cells. (A) Low 382
power view of a PAS-stained portion of hamster nasal cavity demonstrating morphology 383
of olfactory and respiratory epithelia (Box 1, enlarged in panel B) and FAE with M cells 384
overlying the NALT (Box 2, enlarged in panel C; FAE indicated by asterisks). (B) RE 385
can be distinguished from OE based on the thickness of the epithelial layer and the 386
length of cilia. (C) M cells can be identified by their distinct morphology, including 387
intraepithelial pockets (outlined) and lack of cilia which distinguish them from 388
neighboring goblet and respiratory epithelial cells. (D) An H&E stained tissue section 389
from a hamster extranasally exposed to 20 µl India ink that survived for 30 minutes prior 390
to perfusion; note the presence of ink particles within a subset of M cells of the FAE. 391
Asterisks indicate air space. OE, olfactory epithelium; RE, respiratory epithelium; FAE, 392
follicle associated epithelium; NALT, nasal associated lymphoid tissue. Bars: A, 200 µm; 393
B,C,D 20 µm. 394
Figure 2. Uninfected and infected brain homogenate in the hamster nasal cavity after 395
inhalation identified with GFAP and PrPSc IHC. (A) A low power view of a portion of a 396
nasal turbinate in the nasal cavity of a hamster extranasally inoculated with mock-397
infected brain homogenate that survived for 5 minutes prior to perfusion, processed 398
using GFAP IHC. The area outlined in the box is enlarged in panel B. (B) Higher power 399
view of the uninfected brain homogenate identified using GFAP IHC and an adjacent 400
tissue section (C) processed using PrPSc IHC. Note the lack of punctate 401
immunoreactivity in C, indicating the brain homogenate contains GFAP, but lacks PrPSc. 402
(D) A low power view of a portion of a nasal turbinate in the nasal cavity of a hamster 403
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
21
extranasally inoculated with HY TME-infected brain homogenate that survived for 5 404
minutes prior to perfusion, processed using GFAP IHC. The area outlined in the box is 405
enlarged in panel E. Note the GFAP labeled bundle of nonmyelinating Schwann cells in 406
the lamina propria indicated by an arrow. (E) GFAP labeled brain homogenate from HY 407
TME-infected animal and an adjacent tissue section (F) processed using PrPSc IHC. 408
Note the distinct punctate labeled brain homogenate that is characteristic of PrPSc, 409
indicating this section contains GFAP and PrPSc. Contrast the staining in panels C and 410
F to note the distinction between PrPSc-negative and PrPSc-positive brain homogenate. 411
Asterisks indicate air space. Bars, A,D 100 µm; B,C,E,F 20 µm. 412
Figure 3. Transcellular transport of prions by M cells in the nasal cavity following 413
inhalation. Inhaled mock-infected brain homogenate (A) and prion-infected brain 414
homogenate (B) identified with GFAP IHC located on the surface of the FAE of 415
hamsters. Note the lack of brain homogenate within the M cells of the FAE in either of 416
these sections; (A) taken from an animal that survived 5 minutes till perfusion and (B) 417
from an animal that survived 1 minute till perfusion. Infected brain homogenate 418
identified with GFAP IHC (C) and PrPSc IHC (D) within M cells (indicated by arrows) of 419
animals that survived 10 minutes (C) and 5 minutes (D) till perfusion. Asterisks indicate 420
air space. Bars, A,B 50 µm; C,D 20 µm. 421
Figure 4. Paracellular transport of brain homogenate in the nasal cavity following 422
inhalation identified with GFAP IHC. Inhaled mock (A) and infected (B) brain 423
homogenate crossing the nasal mucosa between cells of the olfactory epithelium 5 424
minutes (A) and 1 minute (B) after inhalation. Brain homogenate could be seen 425
between epithelial cells spanning the complete width of the epithelium and entering the 426
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
22
underlying lamina propria on some tissue sections (C). Note that multiple examples of 427
paracellular transport of infected (B, C, D) and uninfected (E) brain homogenate were 428
observed on some tissue sections. Transport of brain homogenate was noted across 429
olfactory (C), respiratory (D) and FAE (E). Nonmyelinating Schwann cells deep to the 430
FAE are labeled with GFAP IHC and indicated by arrows. Note the width of the 431
paracellular transport appears to be approximately the same width as that of a single 432
epithelial cell in all the panels. NS, nasal septum. Bars, A,B 100 µm; C,D,E 25 µm. 433
Figure 5. Brain homogenate was located within the lumen of lymphatic vessels of the 434
lamina propria of the nasal cavity within minutes of inhalation, and was still visible for 435
hours after inhalation. Infected (A,D) and uninfected (B,C) brain homogenate was 436
located within lymphatics 5 min (A,B) and 60 min (C,D) after inhalation. Bars, A,B,C,D 437
50 µm. 438
439
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
23
References 440
1. Adams DR, McFarland LZ. 1972. Morphology of the nasal fossae and associated structures of the 441
hamster (Mesocricetus auratus). J. Morphol. 137:161-180. 442
2. Andréoletti O, Lacroux C, Chabert A, Monnereau L, Tabouret G, Lantier F, Berthon P, Eychenne F, 443
Lafond-Benestad S, Elsen J-M, Schelcher F. 2002. PrPsc accumulation in placentas of ewes exposed to 444
natural scrapie: influence of foetal PrP genotype and effect on ewe-to-lamb transmission. J. Gen. Virol. 445
83:2607-2616. 446
3. Åkesson CP, McGovern G, Dagleish MP, Espenes A, Press CM, Landsverk T, Jeffrey M. 2011. 447
Exosome-producing follicle associated epithelium is not involved in uptake of PrP from the gut of sheep 448
(Ovis aries): an ultrastructural study. PLoS ONE 6:e22180. 449
4. Angers RC, Seward TS, Napier D, Green M, Hoover E, Spraker T, O’Rourke K, Balachandran A, Telling 450
GC. 2009. Chronic wasting disease prions in elk antler velvet. Emerg. Infect. Dis. 15:696-703. 451
5. Berk DA, Swartz MA, Leu AJ, Jain RK. 1996. Transport in lymphatic capillaries. II. Microscopic velocity 452
measurement with fluorescence photobleaching. Am. J. Physiol. 270:H330-H337. 453
6. Bessen RA, Martinka S, Kelly J, Gonzalez D. 2009. Role of the lymphoreticular system in prion 454
neuroinvasion from the oral and nasal mucosa. J. Gen. Virol. 83:6435-6445. 455
7. Bessen RA, Shearin H, Martinka S, Boharski R, Lowe D, Wilham JM, Caughey B, Wiley JA. Prion 456
shedding from olfactory neurons into nasal secretions. PLoS Pathog. 6:e1000837. 457
8. Bolton DC, McKinley MP, Prusiner SB. 1982. Identification of a protein that purifies with the scrapie 458
prion. Science 218:1309-1311. 459
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
24
9. Bolton DC, McKinley MP, Prusiner SB. 1984. Molecular characteristics of the major scrapie prion 460
protein. Biochemistry 23:5898-5906. 461
10. Brown P, Gajdusek DC. 1991. Survival of scrapie virus after 3 years’ internment. Lancet 337:269-462
270. 463
11. Bullen TF, Forrest S, Campbell F, Dodson AR, Hershmann MJ, Pritchard DM, Turner JR, Montrose 464
MH, Watson AJM. 2006. Characterization of epithelial cell shedding from human small intestine. Lab. 465
Invest. 86:1052-1063. 466
12. Castilla J, Saa P, Hetz C, Soto C. 2005. In vitro generation of infectious scrapie prions. Cell 121:195-467
206. 468
13. Castilla J, Saa P, Soto C. 2005. Detection of prions in blood. Nat. Med. 11:982-985. 469
14. Caughey B, Baron GS. 2006. Prions and their partners in crime. Nature 443:803-810. 470
15. Centers for Disease Control. http://www.cdc.gov/ncidod/dvrd/cwd: chronic wasting disease (CWD). 471
Date Accessed: July 23, 2012. 472
16. Collee GJ, Bradley R. 1997. BSE: A decade on—part 1. Lancet 349: 636-641. 473
17. Collins SR, Douglass A, Vale RD, Weissman JS. 2004. Mechanism of prion propagation: Amyloid 474
growth occurs by monomer addition. PLoS Biology 2:1582-1590. 475
18. Deleault NR, Harris BT, Rees JR, Supattapone S. 2007. Formation of native prions from minimal 476
components in vitro. Proc. Natl. Acad. Sci. U.S.A. 104:9741-9746. 477
19. Denkers ND, Seelig DM, Telling GC, Hoover EA. 2010. Aerosol and nasal transmission of chronic 478
wasting disease in cervidized mice. J. Gen. Virol. 91:1651-1658. 479
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
25
20. Donaldson DS, Kobayashi A, Ohno H, Williams IR, Mabbott NA. 2012. M cell-depletion blocks oral 480
prion disease pathogenesis. Nature 5:216-225. 481
21. Eng LF, Ghirnikar RS, Lee YL. 2000. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). 482
Neurochem. Res. 25:1439-1451. 483
22. Ermak TH, Giannasca PJ. 1998. Microparticle targeting to M cells. Adv. Drug Deliv. Rev. 34:261-283. 484
23. Fischer M, Franzeck UK, Herrig I, Costanzo U, Wen S, Schiesser M, Hoffmann U, Bollinger A. 1996. 485
Flow velocity of single lymphatic capillaries in human skin. Am. J. Physiol. 270:H358-H363. 486
24. Fontaine SN, Brown DR. 2009. Mechanism of prion protein aggregation. Protein Pept. Lett. 16:14-487
26. 488
25. Foster N, Macpherson GG. Murine cecal patch M cells transport infectious prions in vivo. J. Infect. 489
Dis. 202:000-000. 490
26. Gajdusek, D.C. 1977. Unconventional viruses and the origin and disappearance of kuru. Science 491
197:943-960. 492
27. Giannasca PJ, Boden JA, Monath TP. 1997. Targeted delivery of antigen to hamster nasal lymphoid 493
tissue with M-cell-directed lectins. Infect. Immun. 65:4288-4298. 494
28. Griffin JW, Thompson WJ. 2008. Biology and pathology of nonmyelinating Schwann cells. Glia 495
56:1518-1531. 496
29. Grubb BR, Jones JH, Boucher RC. 2004. Mucociliary transport determined by in vivo microdialysis in 497
the airways of normal and CF mice. Am. J. Physiol. Lung Cell Mol. Physiol. 286: L588-L595. 498
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
26
30. Gudmundur G, Sigurdarson S, Brown P. 2006. Infectious agent of sheep scrapie may persist in the 499
environment for at least 16 years. J. Gen. Virol. 87:3737-3740. 500
31. Haley NJ, Mathiason CK, Zabel MD, Telling GC, Hoover EA. 2009. Detection of CWD prions in urine 501
and saliva of deer by transgenic mouse bioassay. PLoS ONE 4:e4848. 502
32. Hamir AN, Kunkle RA, Richt JA, Miller JM, Greenlee JJ. 2008. Experimental transmission of US 503
scrapie agent by nasal, peritoneal, and conjunctival routes to genetically susceptible sheep. Vet. Pathol. 504
45:1-6. 505
33. Harkema JR, Carey SA, Wagner JG. 2006. The nose revisited: A brief review of the comparative 506
structure, function, and toxicologic pathology of the nasal epithelium. Tox. Path. 34:252-269. 507
34. Haybaeck J, Heikenwalder M, Klevenz B, Schwarz P, Margalith I, Bridel C, Mertz K, Zirdum E, 508
Petsch B, Fuchs TJ, Stitz L, Aguzzi A. 2011. Aerosols transmit prions to immunocompetent and 509
immunodeficient mice. PLoS Pathog. 7:e1001257. 510
35. Heppner FL, Christ AD, Klein MA, Prinz M, Fried M, Kraehenbuhl J-P, Aguzzi A. 2001. 511
Transepithelial prion transport by M cells. Nat. Med. 7:976-977. 512
36. Huang F-P, Farquhar CF, Mabbot NA, Bruce ME, MacPherson GG. 2002. Migrating intestinal 513
dendritic cells transport PrPsc from the gut. J. Gen. Virol. 83:267-271. 514
37. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F. 2002. 515
Transmission of prion diseases by blood transfusion. J. Gen. Virol. 83:2897-2905. 516
38. Jeffrey M, González L, Espenes A, Press CMcL, Martin S, Chaplin M, Davis L, Landsverk T, 517
MacAldowie C, Eaton S, McGovern G. 2006. Transportation of prion protein across the intestinal 518
mucosa of scrapie-susceptible and scrapie-resistant sheep. J. Pathol. 209:4-14. 519
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
27
39. Jessen KR, Morgan L, Stewart HJS, Mirsky R. 1990. Three markers of adult non-myelin-forming 520
Schwann cells, 217c (Ran-1), A5E3 and GFAP: development and regulation by neuron—Schwann cell 521
interactions. Development 109:91-103. 522
40. Johnson CJ, Phillips KE, Schramm PT, McKenzie D, Aiken JM, Pedersen JA. 2006. Prions adhere to 523
soil minerals and remain infectious. PLos Pathog. 2:296-302. 524
41. Kiesslich R, Goetz M, Angus EM, Hu Q, Guan Y, Potten C, Allen T, Neurath MF, Shroyer NF, 525
Montrose MH, Watson AJM. 2007. Identification of epithelial gaps in human small and large intestine 526
by confocal endomicroscopy. Gastroenterology 133:1769-1778. 527
42. Kincaid AE, Bartz JC. 2007. The nasal cavity is a route for prion infection in hamsters. J. Virol. 528
81:4482-4491. 529
43. Konold T, Moore SJ, Bellworthy SJ, Simmons HA. 2008. Evidence of scrapie transmission via milk. 530
BMC Vet. Res. 4:14. 531
44. Kraehenbuhl J-P, Neutra MR. 2000. Epithelial M cells: differentiation and function. Annu. Rev. Cell 532
Dev. Biol. 16:301-332. 533
45. Kruger D, Thomzig A, Lenz G, Kampf K, McBride P, Beekes M. 2009. Faecal shedding, alimentary 534
clearance and intestinal spread of prions in hamsters fed with scrapie. 2009. Vet. Res. 40:4. 535
46. Kujala P, Raymond CR, Romeijn M, Godsave SF, van Kasteren SI, Wille H, Prusiner SB, Mabbott NA, 536
Peters PJ. 2011. Prion uptake in the gut: identification of the first uptake and replication sites. PLoS 537
Pathogens 7:e1002449. 538
47. Lacroux C, Simon S, Benestad SL, Maillet S, Mathey J, Lugan S, Corbiere F, Cassard H, Costes P, 539
Bergonier D, Weisbecker J-L, Moldal T, Simmons H, Lantier F, Feraudet-Tarise C, Morel N, Schelcher F, 540
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
28
Grassi J, Andreoletti O. 2008. Prions in milk from ewes incubating natural scrapie. PLoS Pathog. 541
4:e1000238. 542
48. Maddison BC, Baker CA, Rees HC, Terry LA, Thorne L, Bellworthy SJ, Whitelam GC, Gough KC. 543
2009. Prions are secreted in milk from clinically normal scrapie-exposed sheep. J. Virol. 83:8293-8296. 544
49. Maddison BC, Baker CA, Terry LA, Bellworthy SJ, Thorne L, Rees HC, Gough KC. 2010. 545
Environmental sources of scrapie prions. J. Virol. 84:11560-11562. 546
50. Maddison BC, Rees HC, Baker CA, Taema M, Bellworthy SJ, Thorne L, Terry LA, Gough KC. 2010. 547
Prions are secreted into the oral cavity in sheep with preclinical scrapie. J. Infect. Dis. 201:1672-1676. 548
51. Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov 549
IV. 2010. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. 550
Acta Neuropathol. 119:177-187. 551
52. Marsh RF, Hadlow WJ. 1992. Transmissible mink encephalopathy. Rev. sci. tech. Off. int. Epiz. 552
11(2):539-550. 553
53. Mathiason CK, Powers JG, Dahmes SJ, Osborn DA, Miller KV, Warren RJ, Mason GL, Hays SA, 554
Hayes-Klug J, Seelig DM, Wild MA, Wolfe LL, Spraker TR, Miller MW, Sigurdson CJ, Telling GC, Hoover 555
EA. 2006. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 556
314:133-136. 557
54. Miller MW, Conner MM. 2005. Epidemiology of chronic wasting disease in free-ranging mule deer: 558
spatial, temporal and demographic influences on observed prevalence patterns. J. Wildl. Dis. 41:275-559
290. 560
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
29
55. Miller MW, Wild MA. 2004. Epidemiology of chronic wasting disease in captive white-tailed deer 561
and mule deer. J. Wildl. Dis. 40:320-327. 562
56. Miller MW, Williams ES, Hobbs NT, Wolfe LL. 2004. Environmental sources of prion transmission in 563
mule deer. Emerg. Infect. Dis. 10:1003-1006. 564
57. Miller MW, Williams ES, McCarty CW, Spraker TR, Kreeger TJ, Larsen CT, Thorne ET. 2000. 565
Epizootiology of chronic wasting disease in free-ranging cervids in Colorado and Wyoming. J. Wildl. Dis. 566
36:676-690. 567
58. Mishra RS, Basu S, Guy Y, Luo X, Zou W-Q, Mishra R, Li R, Chen SG, Gambetti P, Fujioka H, Singh N. 568
2004. Protease-resistant human prion protein and ferritin are cotransported across caco-2 epithelial 569
cells: implications for species barrier in prion uptake from the intestine. J. Neurosci. 24:11280-11290. 570
59. Miyazawa K, Kanaya T, Takakura I, Tanaka S, Hondo T, Watanabe H, Rose M, Kitazawa H, 571
Yamaguchi T, Katamine S, Nishida N, Aso H. 2010. Transcytosis of murine-adapted bovine spongiform 572
encephalopathy agents in an in vitro bovine M cell model. J. Virol. 84:12285-12291. 573
60. Morel E, Andrieu T, Casagrande F, Gauczynski S, Weiss S, Grassi J, Rousset M, Dormont D, 574
Chambaz J. 2005. Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin 575
receptor. Am. J. Pathol. 167:1033-1042. 576
61. Morgan KT, Jiang X-Z, Patterson DL, Gross EA. 1984. The nasal mucociliary apparatus: correlation of 577
structure and function in the rat. Am. Rev. Respir. Dis. 130:275-281. 578
62. Murayama Y, Yoshioka M, Okada H, Takata M, Yokoyama T, Mohri S. 2007. Urinary excretion and 579
blood level of prions in scrapie-infected hamsters. J. Gen. Virol. 88:2890-2898. 580
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
30
63. National Research Council. 1996. Guide for the care and use of laboratory animals. National 581
Academy Press, Washington DC. 582
64. Okamoto M, Furuoka H, Horiuchi M, Noguchi T, Hagiwara K, Muramatsu Y, Tomonaga K, Tsuji M, 583
Ishihara C, Ikuta K, Taniyama H. 2003. Experimental transmission of abnormal prion protein (PrPsc) in 584
the small intestinal epithelial cells of neonatal mice. Vet. Pathol. 40:723-727. 585
65. Owen RL. 1999. Uptake and transport of intestinal macromolecules and microorganisms by M cells 586
in Peyer’s patches—a personal and historical perspective. Semin. Immunol. 11:157-163. 587
66. Pan K-M, Stahl N, Prusiner SB. 1992. Purification and properties of the cellular prion protein from 588
Syrian hamster brain. Pro. Sci. 1:1343-1352. 589
67. Pappo J, Ermak TH. 1989. Uptake and translocation of fluorescent latex particles by rabbit Peyer’s 590
patch follicle epithelium: a quantitative model for M cell uptake. Clin. Exp. Immunol. 76:144-148. 591
68. Race R, Jenny A, Sutton D. 1998. Scrapie infectivity and proteinase K-resistant prion protein in 592
sheep placenta, brain, spleen and lymph node: Implication for transmission and antemortem diagnosis. 593
J. Infect. Dis. 178:949-953. 594
69. Rosner AJ, Keren DF. 1984. Demonstration of M cells in the specialized follicle-associated 595
epithelium overlying isolated lymphoid follicles in the gut. J. Leukocyte Biol. 35: 397-404. 596
70. Rubenstein R, Bulgin MS, Chang B, Sorensen-Melon S, Petersen RB, LaFauci G. 2012. PrPSc 597
detection and infectivity in semen from scrapie-infected sheep. J. Gen. Virol. 93:1375-1383. 598
71. Safar JG, Lessard P, Tamgüney G, Freyman Y, Deering C, Letessier F, DeArmond SJ, Prusiner SB. 599
2008. Transmission and detection of prions in feces. J. Infect. Dis. 198:1-9. 600
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
31
72. Saunders SE, Bartelt-Hunt SL, Bartz JC. 2008. Prions in the environment: occurrence, fate and 601
mitigation. Prion 2:162-169. 602
73. Sbriccoli M, Cardone F, Valanzano A, Lu M, Graziano S, De Pascalis A, Ingrosso L, Zanusso G, 603
Monaco S, Bentivoglio M, Pocchiari M. 2008. Neuroinvasion of the 263K scrapie strain after intranasal 604
administration occurs through olfactory-unrelated pathways. Acta. Neuropathol. 117:175-184. 605
74. Seeger H, Heikenwalder M, Zeller N, Kranich J, Schwarz P, Gaspert A, Seifert B, Miele G, Aguzzi A. 606
2005. Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 310:324-326. 607
75. Seidel B, Thomzig A, Buschmann A, Groschup MH, Peters R, Beekes M, Terytze K. 2007. Scrapie 608
agent (Strain 263K) can transmit disease via the oral route after persistence in soil over years. PLoS ONE 609
2:e435. 610
76. Shaked GM, Shaked Y, Kariv-Inbal Z, Halimi M, Avraham I, Gabizon R. 2001. A protease-resistant 611
prion protein isoform is present in urine of animals and humans affected with prion diseases. J. Bio. 612
Chem. 276:31479-31482. 613
77. Sigurdson CJ. 2008. A prion disease of cervids: chronic wasting disease. Vet. Res. 39:41. 614
78. Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, Schwarz P, Ott D, Ruicke T, 615
Liberski PP, Julius C, Falsig J, Stitz L, Wuthrich K, Aguzzi A. 2009. De novo generation of a transmissible 616
spongiform encephalopathy by mouse transgenesis. Proc. Natl. Acad. Sci. U.S.A. 106:304-309. 617
79. Sigurdson CJ, Williams ES, Miller MW, Spraker TR, O’Rourke KI, Hoover EA. 1999. Oral transmission 618
and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). 619
J. Gen. Virol. 80:2757-2764. 620
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from
32
80. Sunkesula SRB, Luo X, Das D, Singh A, Singh N. 2010. Iron content of ferritin modulates its uptake 621
by intestinal epithelium: implications for co-transport of prions. Molecular Brain 3:14. 622
81. Swartz MA. 2001. The physiology of the lymphatic system. Adv. Drug Deliv. Rev. 50:3-20. 623
82. Swartz MA, Berk DA, Jain RK. 1996. Transport in lymphatic capillaries. I. Macroscopic 624
measurements using residence time distribution theory. Am. J. Physiol. 270:H324-H329. 625
83. Takakura I, Miyazawa K, Kanaya T, Itani W, Watanabe K, Ohwada S, Watanabe H, Hondo T, Rose 626
MT, Mori T, Sakaguchi S, Nishida N, Katamine S, Yamaguchi T, Aso H. 2011. Orally administered prion 627
protein is incorporated by M cells and spreads into lymphoid tissues with macrophages in prion protein 628
knockout mice. Am. J. Pathol. 179:1-9. 629
84. Tamgüney G, Miller MW, Wolfe LL, Sirochman TM, Glidden DV, Palmer C, Lemus A, DeArmond SJ, 630
Prusiner SB. 2009. Asymptomatic deer excrete infectious prions in faeces. Nature 461:529-532. 631
85. Wang F, Wang X, Yuan C-G, Ma J. 2010. Generating a prion with bacterially expressed recombinant 632
prion protein. Science 327:1132-1135. 633
86. Watson AJM, Duckworth CA, Guan Y, Montrose MH. 2009. Mechanisms of epithelial cell shedding 634
in the mammalian intestine and maintenance of barrier function. Ann. N.Y. Acad. Sci. 1165:135-142. 635
87. Williams ES, Young S. 1980. Chronic wasting disease of captive mule deer: a spongiform 636
encephalopathy. J. Wildl. Dis. 16:89-98. 637
88. Yoffey JM, Drinker CK. 1938. The lymphatic pathway from the nose and pharynx: the absorption of 638
dyes. J. Exp. Med. 68:629-645. 639
640
641
on April 16, 2018 by guest
http://jvi.asm.org/
Dow
nloaded from